Dr. Jose Mari Ortiz, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121 Phone: 502-624-9007 Fax: 502-624-0252 |
Dr. Brian Jacobs Shiozawa, MD, MPH, MHA, FACOEM Medicare: Not Enrolled in Medicare Practice Location: 200 Brule St Bldg 871, Fort Knox, KY 40121 Phone: 502-626-9743 |
Dr. William Harold Candler Jr., D.O. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121 Phone: 502-624-9007 Fax: 502-624-0252 |
News Archive
In the first article in a special report titled "The Seven Million," which looks at "the many challenges faced worldwide in an effort to reduce child mortality" and is "supported through a partnership with the Kaiser Family Foundation," GlobalPost examines the implications of U.S. budget negotiations on global health spending.
Researchers from the University of Eastern Finland have discovered a likely cause for visual impairment and eventual loss of vision in the Finnish variant of Neuronal Ceroid Lipofuscinosis.
"Patients admitted to an intensive care unit over the weekend may be more likely to die than those admitted at other times, perhaps because of reduced staffing, a review of research finds," HealthDay/USA Today reports. "For the review, published in the July issue of the journal Chest, researchers examined the results of 10 studies exploring the link between time of admission to an ICU and death rates.
Prescribing a medication plan for a patient with Parkinson's disease is a big challenge for doctors, but now a University of Rhode Island biomedical engineering professor and his students are making great strides in solving that problem with their groundbreaking research.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 4 days ago